...
首页> 外文期刊>Drug development and industrial pharmacy >Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation
【24h】

Fast dissolving electrospun polymeric films of anti-diabetic drug repaglinide: formulation and evaluation

机译:快速溶解抗糖尿病药物常规膜的抗糖尿病药物repaglinide:配方和评价

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: Repaglinide is a well-known FDA approved drug from category of meglitinide; used for the treatment of diabetes. However, its use is limited because of its poor water solubility which leads to erratic drug absorption. Present work focuses on formulation and evaluation of polyvinyl alcohol (PVA)-polyvinyl pyrrolidone (PVP) nanofibers to counter this problem of poor water solubility. Significance: Prepared nanofibers with hydrophilic polymers were expected to tackle the problem of poor water solubility. Methods: Nanofibers were prepared by electrospinning technique with the optimization of parameters affecting final product. Further prepared formulation was characterized using various techniques. Results: Successful development of drug loaded nanofibers was commenced utilizing electrospinning technique. Further casted film of same polymeric blend was prepared and compared with nanofibers. Optimized nanofibers showed an average diameter of 600-800 nm with smooth surface morphology. Prepared nanofibers and casted film was analyzed in terms of surface morphology, mechanical strength, solid state of drug present, effects of hydrogen bond formation and drug release profile. Results from the glucose tolerance test suggested both the formulations to be having better control over glucose levels as compared to free drug. Conclusion: Overall developed nanofibers presented themselves to be potential drug delivery candidates for drugs having poor water solubility.
机译:目的:Repaglinide是一个着名的FDA批准来自Meglitinide类别的药物;用于治疗糖尿病。然而,它的使用是有限的,因为其水溶解度差导致不稳定的药物吸收。目前的工作侧重于聚乙烯醇(PVA) - 聚乙烯吡咯烷酮(PVP)纳米纤维的配方和评价,以反对水溶性差的情况。意义:预期使用亲水性聚合物制备的纳米纤维来解决水溶解度差的问题。方法:通过静电纺丝技术通过优化影响最终产品的参数来制备纳米纤维。使用各种技术表征进一步制备的制剂。结果:采用静电纺丝技术开始成功开发药物负载纳米纤维。制备相同聚合物共混物的进一步浇铸薄膜并与纳米纤维进行比较。优化的纳米纤维显示平均直径为600-800nm,具有光滑的表面形态。在表面形态,机械强度,存在的药物存在的情况下,分析了制备的纳米纤维和浇铸薄膜,氢键形成和药物释放曲线的作用。葡萄糖耐量试验结果表明,与游离药物相比,配方均具有更好地控制葡萄糖水平。结论:整体开发的纳米纤维呈现出潜在的药物输送候选药,用于水溶性差的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号